Over 350 Brand-Name Drugs See a Price Increase in 2026

Pharmaceutical manufacturers are planning to raise list prices on at least 350 brand-name medications in the United States beginning in 2026, up from 250 drugs last year, according to new data from health care research firm 3 Axis Advisors. These increases reflect...

Transparency, Value Commitment Counter PBM Concerns

A new playbook from the National Alliance of Healthcare Purchaser Coalitions lists the top 10 concerns employer health plans have with pharmacy benefit managers (PBMs): Promoting drugs with higher prices when lower-price options are availableOffering preferred...